Pharsight

Spy Agent Green Kit is owned by Novadaq Tech.

Spy Agent Green Kit contains Indocyanine Green.

Spy Agent Green Kit has a total of 5 drug patents out of which 0 drug patents have expired.

Spy Agent Green Kit was authorised for market use on 21 November, 2018.

Spy Agent Green Kit is available in powder;intravenous, interstitial dosage forms.

Spy Agent Green Kit can be used as measuring time-varying change in blood in a tissue volume using modified beer-lambert law in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery, visualization of vessels, blood flow and tissue perfusion of vessel with arteriovenous malformation in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery, visualization of vessels, blood flow and tissue perfusion of donor organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; visualization of extrahepatic biliary duct attached to donor organ in patients 12 years and older, visualization of extrahepatic biliary duct attached to transplanted organ in patients 12 years and older; visualization of vessels, blood flow and tissue perfusion of transplanted organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery, visualization of vessels, blood flow and tissue perfusion in surgical flaps in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery.

The generics of Spy Agent Green Kit are possible to be released after 04 August, 2035.

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9421280	NOVADAQ TECH	Real time imaging during solid organ transplant	Nov, 2025 (2 years from now)
US8185176	NOVADAQ TECH	Method and apparatus for vasculature visualization with applications in neurosurgery and neurology	Jun, 2028 (5 years from now)
US8647605	NOVADAQ TECH	Real time imaging during solid organ transplant	Feb, 2029 (6 years from now)
US8406860	NOVADAQ TECH	Method for evaluating blush in myocardial tissue	Apr, 2029 (6 years from now)
US10631746	NOVADAQ TECH	Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography	Aug, 2035 (12 years from now)

Drugs and Companies using INDOCYANINE GREEN ingredient

Market Authorisation Date: 21 November, 2018

Treatment: Visualization of vessels, blood flow and tissue perfusion of donor organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; Visualization of extrahepatic biliary duct attached to donor organ in patients 12 years and older; Visualization of vessels, blood flow and tissue perfusion of vessel with arteriovenous malformation in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; Visualization of extrahepatic biliary duct attached to transplanted organ in patients 12 years and older; Visualization of vessels, blood flow and tissue perfusion of transplanted organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; Visualization of vessels, blood flow and tissue perfusion in surgical flaps in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery; Measuring time-varying change in blood in a tissue volume using modified beer-lambert law in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery

Dosage: POWDER;INTRAVENOUS, INTERSTITIAL